It was found that miR-198 transcription is reduced in pancreatic cancer and that miR-198 inhibition increases PBX-1 and VCP expression; dysregulation of the PBX-1/VCP axis enhances tumorigenicity. This evidence concerns the gene PBX1 and familial pancreatic carcinoma.